Logo image of ALGEV.PA

GEVELOT SA (ALGEV.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:ALGEV - FR0000033888 - Common Stock

178 EUR
-1 (-0.56%)
Last: 12/12/2025, 7:00:00 PM
Fundamental Rating

4

ALGEV gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 109 industry peers in the Machinery industry. While ALGEV has a great health rating, there are worries on its profitability. ALGEV has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

ALGEV had positive earnings in the past year.
In the past year ALGEV had a positive cash flow from operations.
In the past 5 years ALGEV has always been profitable.
ALGEV had a positive operating cash flow in 4 of the past 5 years.
ALGEV.PA Yearly Net Income VS EBIT VS OCF VS FCFALGEV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

ALGEV has a Return On Assets of 1.21%. This is in the lower half of the industry: ALGEV underperforms 66.06% of its industry peers.
Looking at the Return On Equity, with a value of 1.52%, ALGEV is doing worse than 67.89% of the companies in the same industry.
The Return On Invested Capital of ALGEV (0.76%) is worse than 77.06% of its industry peers.
ALGEV had an Average Return On Invested Capital over the past 3 years of 3.04%. This is significantly below the industry average of 8.88%.
Industry RankSector Rank
ROA 1.21%
ROE 1.52%
ROIC 0.76%
ROA(3y)2.68%
ROA(5y)2.17%
ROE(3y)3.82%
ROE(5y)3.1%
ROIC(3y)3.04%
ROIC(5y)2.57%
ALGEV.PA Yearly ROA, ROE, ROICALGEV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8

1.3 Margins

With a Profit Margin value of 2.38%, ALGEV is not doing good in the industry: 60.55% of the companies in the same industry are doing better.
ALGEV's Profit Margin has declined in the last couple of years.
The Operating Margin of ALGEV (1.68%) is worse than 76.15% of its industry peers.
In the last couple of years the Operating Margin of ALGEV has declined.
ALGEV has a Gross Margin of 63.62%. This is amongst the best in the industry. ALGEV outperforms 88.99% of its industry peers.
In the last couple of years the Gross Margin of ALGEV has remained more or less at the same level.
Industry RankSector Rank
OM 1.68%
PM (TTM) 2.38%
GM 63.62%
OM growth 3Y-37.75%
OM growth 5Y-26.99%
PM growth 3Y-30.66%
PM growth 5Y-22.17%
GM growth 3Y-1.14%
GM growth 5Y-0.99%
ALGEV.PA Yearly Profit, Operating, Gross MarginsALGEV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ALGEV is destroying value.
Compared to 1 year ago, ALGEV has less shares outstanding
Compared to 5 years ago, ALGEV has less shares outstanding
ALGEV has a worse debt/assets ratio than last year.
ALGEV.PA Yearly Shares OutstandingALGEV.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K
ALGEV.PA Yearly Total Debt VS Total AssetsALGEV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

ALGEV has an Altman-Z score of 3.69. This indicates that ALGEV is financially healthy and has little risk of bankruptcy at the moment.
ALGEV's Altman-Z score of 3.69 is fine compared to the rest of the industry. ALGEV outperforms 77.98% of its industry peers.
A Debt/Equity ratio of 0.03 indicates that ALGEV is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.03, ALGEV belongs to the top of the industry, outperforming 88.07% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 3.69
ROIC/WACC0.1
WACC7.85%
ALGEV.PA Yearly LT Debt VS Equity VS FCFALGEV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

ALGEV has a Current Ratio of 5.18. This indicates that ALGEV is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 5.18, ALGEV belongs to the top of the industry, outperforming 97.25% of the companies in the same industry.
ALGEV has a Quick Ratio of 3.79. This indicates that ALGEV is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.79, ALGEV belongs to the top of the industry, outperforming 97.25% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.18
Quick Ratio 3.79
ALGEV.PA Yearly Current Assets VS Current LiabilitesALGEV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1

3. Growth

3.1 Past

ALGEV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -96.89%.
Measured over the past years, ALGEV shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -17.19% on average per year.
Looking at the last year, ALGEV shows a small growth in Revenue. The Revenue has grown by 2.81% in the last year.
ALGEV shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.90% yearly.
EPS 1Y (TTM)-96.89%
EPS 3Y-22.49%
EPS 5Y-17.19%
EPS Q2Q%-60.37%
Revenue 1Y (TTM)2.81%
Revenue growth 3Y10.91%
Revenue growth 5Y5.9%
Sales Q2Q%14.91%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y3.55%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.03%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALGEV.PA Yearly Revenue VS EstimatesALGEV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
ALGEV.PA Yearly EPS VS EstimatesALGEV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2 4 6 8 10

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 395.56, the valuation of ALGEV can be described as expensive.
69.72% of the companies in the same industry are cheaper than ALGEV, based on the Price/Earnings ratio.
ALGEV is valuated expensively when we compare the Price/Earnings ratio to 26.54, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 13.15 indicates a correct valuation of ALGEV.
Based on the Price/Forward Earnings ratio, ALGEV is valued a bit cheaper than 68.81% of the companies in the same industry.
ALGEV is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.78, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 395.56
Fwd PE 13.15
ALGEV.PA Price Earnings VS Forward Price EarningsALGEV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

ALGEV's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.3
ALGEV.PA Per share dataALGEV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150 200 250

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ALGEV does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)111.49
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

ALGEV has a Yearly Dividend Yield of 2.79%.
Compared to an average industry Dividend Yield of 2.37, ALGEV pays a better dividend. On top of this ALGEV pays more dividend than 84.40% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.27, ALGEV pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.79%

5.2 History

The dividend of ALGEV is nicely growing with an annual growth rate of 21.15%!
Dividend Growth(5Y)21.15%
Div Incr Years4
Div Non Decr Years5
ALGEV.PA Yearly Dividends per shareALGEV.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

117.62% of the earnings are spent on dividend by ALGEV. This is not a sustainable payout ratio.
ALGEV's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP117.62%
EPS Next 2YN/A
EPS Next 3YN/A
ALGEV.PA Yearly Income VS Free CF VS DividendALGEV.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M
ALGEV.PA Dividend Payout.ALGEV.PA Dividend Payout, showing the Payout Ratio.ALGEV.PA Dividend Payout.PayoutRetained Earnings

GEVELOT SA

EPA:ALGEV (12/12/2025, 7:00:00 PM)

178

-1 (-0.56%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)10-30 2025-10-30
Earnings (Next)N/A N/A
Inst Owners1.21%
Inst Owner ChangeN/A
Ins Owners7.72%
Ins Owner ChangeN/A
Market Cap133.50M
Revenue(TTM)148.53M
Net Income(TTM)3.29M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.79%
Yearly Dividend5.17
Dividend Growth(5Y)21.15%
DP117.62%
Div Incr Years4
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 395.56
Fwd PE 13.15
P/S 0.97
P/FCF N/A
P/OCF 30.9
P/B 0.62
P/tB 0.63
EV/EBITDA 13.3
EPS(TTM)0.45
EY0.25%
EPS(NY)13.53
Fwd EY7.6%
FCF(TTM)-3.7
FCFYN/A
OCF(TTM)5.76
OCFY3.24%
SpS184.19
BVpS288.75
TBVpS284.6
PEG (NY)111.49
PEG (5Y)N/A
Graham Number54.07
Profitability
Industry RankSector Rank
ROA 1.21%
ROE 1.52%
ROCE 1%
ROIC 0.76%
ROICexc 0.85%
ROICexgc 0.87%
OM 1.68%
PM (TTM) 2.38%
GM 63.62%
FCFM N/A
ROA(3y)2.68%
ROA(5y)2.17%
ROE(3y)3.82%
ROE(5y)3.1%
ROIC(3y)3.04%
ROIC(5y)2.57%
ROICexc(3y)3.55%
ROICexc(5y)3.63%
ROICexgc(3y)3.61%
ROICexgc(5y)3.72%
ROCE(3y)3.99%
ROCE(5y)3.37%
ROICexgc growth 3Y-45.56%
ROICexgc growth 5Y-35.96%
ROICexc growth 3Y-45.2%
ROICexc growth 5Y-34.4%
OM growth 3Y-37.75%
OM growth 5Y-26.99%
PM growth 3Y-30.66%
PM growth 5Y-22.17%
GM growth 3Y-1.14%
GM growth 5Y-0.99%
F-Score6
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA 0.85
Cap/Depr 107.05%
Cap/Sales 5.14%
Interest Coverage 250
Cash Conversion 48.26%
Profit Quality N/A
Current Ratio 5.18
Quick Ratio 3.79
Altman-Z 3.69
F-Score6
WACC7.85%
ROIC/WACC0.1
Cap/Depr(3y)120.29%
Cap/Depr(5y)120.78%
Cap/Sales(3y)5.31%
Cap/Sales(5y)6.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-96.89%
EPS 3Y-22.49%
EPS 5Y-17.19%
EPS Q2Q%-60.37%
EPS Next Y3.55%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.81%
Revenue growth 3Y10.91%
Revenue growth 5Y5.9%
Sales Q2Q%14.91%
Revenue Next Year3.03%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-81.83%
EBIT growth 3Y-30.96%
EBIT growth 5Y-22.68%
EBIT Next Year84.55%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-180.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-51.26%
OCF growth 3Y-10.1%
OCF growth 5Y-0.33%

GEVELOT SA / ALGEV.PA FAQ

What is the ChartMill fundamental rating of GEVELOT SA (ALGEV.PA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ALGEV.PA.


What is the valuation status of GEVELOT SA (ALGEV.PA) stock?

ChartMill assigns a valuation rating of 2 / 10 to GEVELOT SA (ALGEV.PA). This can be considered as Overvalued.


How profitable is GEVELOT SA (ALGEV.PA) stock?

GEVELOT SA (ALGEV.PA) has a profitability rating of 3 / 10.


Can you provide the financial health for ALGEV stock?

The financial health rating of GEVELOT SA (ALGEV.PA) is 7 / 10.


What is the expected EPS growth for GEVELOT SA (ALGEV.PA) stock?

The Earnings per Share (EPS) of GEVELOT SA (ALGEV.PA) is expected to grow by 3.55% in the next year.